Data / Form D filings / Calithera Biosciences, Inc.
Calithera Biosciences, Inc.: Form D filings
Calithera Biosciences, Inc., a biotechnology company in South San Francisco, CA, filed 6 Form D notices with the SEC between 2010 and 2014. The latest, on July 31, 2014, reports $16 million sold of a $30 million offering to 19 investors.
Find out what Calithera Biosciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 343 Oyster Point Blvd., Suite 200, South San Francisco, CA, 94080
- Phone
- (650) 870-1000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1496671
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 31, 2014 | New notice | $29,999,999 | $15,999,998 | $14,000,001 | 19 | Jul 1, 2014 | sec.gov |
| Oct 25, 2013 | New notice | $34,999,999 | $27,150,000 | $7,849,999 | 17 | Oct 7, 2013 | sec.gov |
| Dec 31, 2012 | New notice | $10,700,000 | $1,999,999 | $8,700,001 | 4 | Dec 19, 2012 | sec.gov |
| May 31, 2012 | Amendment | $31,501,060 | $7,999,999 | $23,501,061 | 6 | Nov 7, 2011 | sec.gov |
| Nov 10, 2011 | New notice | $31,501,060 | $3,999,999 | $27,501,061 | 6 | Nov 7, 2011 | sec.gov |
| Jul 16, 2010 | New notice | $40,001,280 | $9,999,999 | $30,001,281 | 7 | Jun 17, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Susan M. Molineaux | Executive Officer, Director | |
| Jean M. George | Director | |
| William M. Waddill | Executive Officer | |
| Deepa M. Pakianathan | Director | |
| Jonathan M. Drachman | Director | |
| Ralph E. Christoffersen | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
- Lionheart Health, Inc. $387,500 · Oct 7, 2026
- Rakuten Medical, Inc. $9 million · Oct 6, 2026
- Zonaliz, Inc. $2.5 million · Oct 5, 2026
- Altay Therapeutics, Inc. $15.7 million · Oct 2, 2026
- Sialia Therapeutics, Inc. $1.5 million · Sep 29, 2026
- Vetmab Biosciences, Inc. $11.4 million · Sep 29, 2026
Every Form D from the week of Jul 28, 2014 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Calithera Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.